Verified Nov 2026
Other
·

New York, New York
·
Since 2017
Everest Medicines is a biopharmaceutical company founded in 2017 and headquartered in Shanghai, China, with 500–1,000 employees and estimated revenue of $100–250 million. The company discovers, develops, manufactures, and commercializes therapeutic products and vaccines for renal diseases, infectious diseases, immunology, and oncology, primarily serving Greater China and Asia-Pacific markets with plans for global expansion. It operates a commercial-scale manufacturing facility in Jiashan, China, and maintains an approved product portfolio including Nefecon for IgA Nephropathy and Velsipity for autoimmune disorders.
Everest Medicines at a glance
Revenue
$100-250M
Est. band
Employees
500-1,000
Founded
2017
Headquarters
New York, New York
Industries
Automotive
Electric Vehicles
Medical
Industrial Equipment
Overview
Everest Medicines is a biopharmaceutical company founded in 2017 and headquartered in Shanghai, China, with 500–1,000 employees and estimated revenue of $100–250 million. The company discovers, develops, manufactures, and commercializes therapeutic products and vaccines for renal diseases, infectious diseases, immunology, and oncology, primarily serving Greater China and Asia-Pacific markets with plans for global expansion. It operates a commercial-scale manufacturing facility in Jiashan, China, and maintains an approved product portfolio including Nefecon for IgA Nephropathy and Velsipity for autoimmune disorders.
At a glance
Attribute | Detail |
|---|---|
Founded | 2017 |
Headquarters | New York, New York |
Employees | 500-1,000 |
Revenue | $100-250M (estimated) |
What Everest Medicines makes
The company operates a commercial-scale manufacturing facility and maintains a portfolio of 11 drug candidates, many in late-stage clinical development across renal, infectious, immunological, and oncology indications.
Latest developments
2026-11-16 — Everest Medicines Announces Inclusion of VELSIPITY® and XERAVA® in China's 2026 National Reimbursement Drug List (prnewswire.com)
2026-11-16 — Everest Medicines Shareholders Approve Strategic Cooperation Framework Agreement - TipRanks.com (tipranks.com)
2026-07-07 — Everest Medicines Announces Close of Exclusive Licensing Agreement with Travere Therapeutics for Civorebrutinib (everestmedicines.com)
2026-04-08 — Everest Medicines Signs Share Purchase Agreement with Hasten Biopharmaceuticals (Asia) Limited (everestmedicines.com)
2026-03-23 — Everest Medicines Enters into Asset Purchase Agreement with Corxel Pharmaceuticals to Develop and Commercialize CARDAMYST™ (Etripamil) Nasal Spray in Greater China (everestmedicines.com)
2026-03-17 — Everest Medicines Enters into Letter of Intent with Hasten Biopharmaceuticals (Asia) Limited (everestmedicines.com)
Facilities
Everest Medicines is headquartered in New York, New York. Public sources also reference these locations:
China SHANGHAI, China — globenewswire.com
China — linkedin.com
Company details
Everest Medicines has executed multiple licensing and acquisition agreements in 2026, including exclusive licensing for Civorebrutinib from Travere Therapeutics and an asset purchase agreement for Etripamil nasal spray development in Greater China. Everest Medicines was founded in 2017, has an estimated 500-1,000 employees, and is headquartered in New York, New York.
Frequently asked questions
What does Everest Medicines do?
Everest Medicines is a biopharmaceutical company founded in 2017 and headquartered in Shanghai, China, with 500–1,000 employees and estimated revenue of $100–250 million. The company discovers, develops, manufactures, and commercializes therapeutic products and vaccines for renal diseases, infectious diseases, immunology, and oncology, primarily serving Greater China and Asia-Pacific markets with plans for global expansion. It operates a commercial-scale manufacturing facility in Jiashan, China, and maintains an approved product portfolio including Nefecon for IgA Nephropathy and Velsipity for autoimmune disorders.
Where is Everest Medicines headquartered?
Everest Medicines is headquartered in New York, New York (450 Lexington Avenue, New York, New York, 10017).
When was Everest Medicines founded?
Everest Medicines was founded in 2017.
How big is Everest Medicines?
Everest Medicines has an estimated 500-1,000 employees, with revenue in the $100-250M range (estimated).
Related suppliers
Explore other suppliers in the LightSource directory:
Last verified Nov 2026. Is this your company? Request a correction.
Location & contact
Evaluating suppliers like these?
This profile is part of a public-data sample of the full LightSource directory. Book a demo to see the full LightSource marketplace and supplier discovery platform — 1M+ credible suppliers, with AI-run sourcing events.
